(Q38498583)

3 September 2017

Pharmaceutical advertising revenue and physician organizations: how much is too much? (English)

1 reference

3 September 2017

Glassman PA

1

1 reference

3 September 2017

Hunter-Hayes J

series ordinal

2

1 reference

3 September 2017

Nakamura T

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Western Journal of Medicine

3 September 2017

1 reference

3 September 2017

171

1 reference

3 September 2017

4

1 reference

3 September 2017

234-238

1 reference

A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts

3 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Regulating pharmaceutical advertising: what will work?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Pharmaceutical advertisements in leading medical journals: experts' assessments

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Characteristics of materials distributed by drug companies. An evaluation of appropriateness

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Acceptance of external funds by physician organizations: issues and policy options.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

BMJ should declare its own conflict of interest

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Conflicts of interest: conceptual and normative issues.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Ethics issues in academic-industry relationships in the life sciences: the continuing debate.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Professional organizations and healthcare industry support: ethical conflict?

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Understanding Financial Conflicts of Interest

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Industrial marketing and medical ethics

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305855

Scientific versus commercial sources of influence on the prescribing behavior of physicians

3 December 2018

1 reference

12 December 2020

A matter of influence

1 reference

12 December 2020

Doctors, drug companies, and gifts

1 reference

12 December 2020

Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff

1 reference

12 December 2020

Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives

1 reference

12 December 2020

Addressing the problem of misleading advertising

1 reference

12 December 2020

Pharmaceutical advertisements in medical journals

1 reference

12 December 2020

Pharmaceutical Promotions — A Free Lunch?

1 reference

12 December 2020

Use of adenosine and effectiveness of pharmaceutical marketing

1 reference

12 December 2020

Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary

1 reference

12 December 2020

Pharmaceutical representatives--educators or product marketers?

1 reference

12 December 2020

Making sense of complex interventions

1 reference

12 December 2020

Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view

1 reference

12 December 2020

Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view

1 reference

12 December 2020

Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view

1 reference

12 December 2020

Identifiers

1 reference

3 September 2017

1 reference